Smith & Nephew (SNN) Assets Average (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Assets Average of $10.6 billion for Q4 2025, up 1.21% year-on-year from $10.4 billion in Q4 2024, and little changed on a QoQ basis from $10.5 billion in Q2 2025.
Smith & Nephew (SNN) Assets Average (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Assets Average for 15 consecutive years, with $10.6 billion the latest figure, recorded in Q4 2025.
- Quarterly Assets Average rose 1.21% year-over-year to $10.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.6 billion (up 1.21% YoY) and the FY2025 annual result came in at $10.4 billion, up 100.65% from the prior year.
- Assets Average was little changed at $10.6 billion in Q4 2025 per SNN's latest filing, from $10.5 billion in the prior quarter.
- Over the last five years, Assets Average for SNN reached as high as $10.6 billion in Q4 2025 and fell as low as $14.5 million in Q4 2021.
- A 5-year average of $5.3 billion and a median of $5.3 billion in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2021 — Assets Average sank 99.7% — and 2024, when it soared 69553.33%.
- Year by year, Assets Average stood at $14.5 million in 2021, then advanced by 10.34% to $16.0 million in 2022, then retreated by 6.25% to $15.0 million in 2023, then surged by 69553.33% to $10.4 billion in 2024, then gained by 1.21% to $10.6 billion in 2025.
- According to Business Quant data, Assets Average over the past three periods registered $10.6 billion, $10.5 billion, and $10.4 billion for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.49 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.64 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.02 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.57 Bn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 10.66 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.57 Bn |
| Jun 28, 2025 | 10.52 Bn |
| Dec 31, 2024 | 10.45 Bn |
| Jun 29, 2024 | 5.28 Bn |
| Dec 31, 2023 | 15.00 Mn |
| Dec 31, 2022 | 16.00 Mn |
| Dec 31, 2021 | 14.50 Mn |
| Dec 31, 2020 | 4.77 Bn |
| Jun 30, 2020 | 4.77 Bn |
| Dec 31, 2019 | 4.48 Bn |
| Jun 29, 2019 | 4.49 Bn |
| Dec 31, 2018 | 3.87 Bn |
| Jun 30, 2018 | 3.87 Bn |
| Dec 31, 2017 | 3.68 Bn |
| Dec 31, 2016 | 7.26 Bn |
| Dec 31, 2015 | 7.19 Bn |
| Jun 30, 2015 | 7.26 Bn |
| Dec 31, 2014 | 7.48 Bn |
| Sep 30, 2014 | 7.70 Bn |
| Jun 28, 2014 | 6.84 Bn |